Adiposity and cancer risk: new mechanistic insights from epidemiology
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
Excess body adiposity, commonly expressed as body mass index (BMI), is a risk factor for many common adult cancers. Over the past decade, epidemiological data have shown that adiposity-cancer risk associations are specific for gender, site, geographical population, histological subtype and molecular phenotype. The biological mechanisms underpinning these associations are incompletely understood but need to take account of the specificities observed in epidemiology to better inform future prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic reviews on insulin-like growth factor or adiposity and cancer risk took laboratory, animal, and human evidence into account to judge the plausibility of different mechanisms [40,101].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“based on epidemiological and other evidence, obesity probably increases the risk of several cancers [101,103]”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“Epidemiology studies have provided evidence for an association between obesity-related metabolic and inflammatory factors, including changes in insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and CRC risk.80”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [80]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationAdipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cited by
Items 201–300 of 678
Nutrition Transition and Cancer
Contaldo, F., Santarpia, L., Cioffi, I., & Pasanisi, F. (2020) · Nutrients · doi:10.3390/nu12030795 · Cited by 41
“Specifically, there is strong evidence for the role of chronic inflammation in mediating the obesity–cancer relationship, while the role of insulin and IGF appears to be moderate [44,45].”
BackgroundAdvances in Diet and Physical Activity in Breast Cancer Prevention and Treatment
Khalifa, A., Guijarro, A. I., & Nencioni, A. (2024) · Nutrients · doi:10.3390/nu16142262 · Cited by 41
“Insulin can directly promote tumor development by stimulating cell proliferation and activating the IGF1 system, which controls cell differentiation, proliferation, and apoptosis [197,198].”
BackgroundAsiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 44
“…produced by fat cells, can activate various signaling pathways including mitogen-activated protein kinase (MAPK), adenosine monophosphate-activated protein kinase (AMPK), and phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt) leading to the suppression of tumor formation induction [26,27].”
BackgroundAvoidable cancer cases in the Nordic countries – The impact of overweight and obesity
Andersson, T., Weiderpass, E., Engholm, G., Lund, A.-S. Q., Ólafsdóttir, E. J., Pukkala, E., Stenbeck, M., & Storm, H. H. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.028 · Cited by 38
“In part, the link to cancer may be explained by alterations in the metabolism of endogenous hormones, including sex steroids, insulin, and insulin-like growth factors, distorting the balance between cell proliferation, differentiation and apoptosis or a low-grade chronic inflammatory state promoting tumour development…”
BackgroundObesity and visceral fat: Survival impact in high-grade endometrial cancer
Donkers, H., Fasmer, K. E., McGrane, J., Pijnenborg, J. M. A., Bekkers, R. L. M., Haldorsen, I. S., & Galaal, K. A. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.11.050 · Cited by 38
Deciphering how early life adiposity influences breast cancer risk using Mendelian randomization
Vabistsevits, M., Smith, G. D., Sanderson, E. C. M., Richardson, T. G., Lloyd‐Lewis, B., & Richmond, R. C. (2022) · Communications Biology · doi:10.1038/s42003-022-03272-5 · Cited by 40
Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective
Olivieri, A., Muratov, S., Larsen, S., Luckevich, M., Chan, K., Lamotte, M., & Lau, D. C. W. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01467-w · Cited by 38
“The exception were the scenarios in which the weight-related effect on the studied cancers, mortality, CV disease and knee osteoarthritis surgery were simultaneously removed.”
BackgroundMethodXu, K., Fu, A., Li, Z., Miao, L., Lou, Z., Jiang, K., Lau, C., Su, T., Tong, T., Bao, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45995-5 · Cited by 36
“Numerous studies have demonstrated that obesity is a signi fi cant risk factor for BC and negatively impacts BC outcomes, independent of the BC subtypes 35,36 .”
BackgroundCarreras‐Torres, R., Haycock, P., Relton, C. L., Martin, R. M., Smith, G. D., Kraft, P. L., Gao, C., Tworoger, S. S., Marchand, L. L., Wilkens, L. R., et al. (2016) · Scientific Reports · doi:10.1038/srep31121 · Cited by 35
Kelly, S. P., Lennon, H., Sperrin, M., Matthews, C. E., Freedman, N. D., Albanes, D., Leitzmann, M. F., Renehan, A. G., & Cook, M. B. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy219 · Cited by 36
Self-citationWang, L., Jin, G., Yu, C., Lv, J., Guo, Y., Bian, Z., Yang, L., Chen, Y., Hu, Z., Chen, F., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32394 · Cited by 37
“Heterogeneity in association with previous studies may suggest different patterns of body fatness and cancer incidence between Chinese and Caucasians.”
BackgroundResultInfluentialStroud, A., Dewey, E. N., Husain, F. A., Fischer, J. M., Courcoulas, A. P., Flum, D. R., Mitchell, J. E., Pories, W. J., Purnell, J. Q., & Wolfe, B. M. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.04.012 · Cited by 34
Jiang, S., Zhang, X.-X., Hu, L.-P., Wang, X., Li, Q., Zhang, X., Li, J., Gu, J., & Zhang, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.586757 · Cited by 36
The Obesity Paradox in Lung Cancer: Associations With Body Size Versus Body Shape
Ardesch, F. H., Ruiter, R., Mulder, M., Lahousse, L., Stricker, B. H. C., & Jong, J. C. K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.591110 · Cited by 40
“Although these results seem to be consistent, this inverse association is in conflict with the hypothesis that suggests that obesity is a risk factor for lung cancer (39, 40).”
Characteristics of the gut microbiome profile in obese patients with colorectal cancer
Shoji, M., Sasaki, Y., Abe, Y., Nishise, S., Yaoita, T., Yagi, M., Mizumoto, N., Kon, T., Onozato, Y., Sakai, T., et al. (2021) · JGH Open · doi:10.1002/jgh3.12529 · Cited by 36
Cairat, M., Rinaldi, S., Navionis, A., Romieu, I., Biessy, C., Viallon, V., Olsen, A., Tjønneland, A. M., Fournier, A., Severi, G., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02319-y · Cited by 35
“Therefore, inflammation might differently impact breast cancer risk among pre and postmenopausal women and could be an important pathway which links obesity to postmenopausal breast cancer [8].”
Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis
Inoue‐Yamauchi, A., Itagaki, H., & Oda, H. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx112 · Cited by 34
“The molecular link between obesity and HCC development has been extensively investigated (2,9,10).”
BackgroundDashti, S. G., English, D. R., Simpson, J. A., Karahalios, A., Moreno‐Betancur, M., Biessy, C., Rinaldi, S., Ferrari, P., Tjønneland, A. M., Halkjær, J., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0965 · Cited by 36
“In women with obesity, adipose tissue secretes less adiponectin (an anti-inflammatory adipocytokine) and more inflammatory adipocytokines (4).”
BackgroundIncidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study
Sylow, L., Grand, M. K., von Heymann, A., Persson, F., Siersma, V., Kriegbaum, M., Andersen, C. L., & Johansen, C. (2022) · Diabetes Care · doi:10.2337/dc22-0232 · Cited by 33
The role of obesity and bariatric surgery-induced weight loss in breast cancer
Bohm, M. S., Sipe, L. M., Pye, M. E., Davis, M. J., Pierre, J. F., & Makowski, L. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10050-6 · Cited by 35
Cancers in France in 2015 attributable to high body mass index
Arnold, M., Touillaud, M. S., Dossus, L., Freisling, H., Bray, F., Margaritis, I., Deschamps, V., & Soerjomataram, I. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.11.006 · Cited by 37
“To-date, the link between cancer and obesity can be explained by three main mechanisms: alterations in sex hormone metabolism, insulin and insulin-like growth factor signalling and the dysregulation of adipose tissue-derived inflammation, which can promote tumour development [27].”
BackgroundRaut, P. K., & Park, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114186 · Cited by 34
Colorectal Cancer and Central Obesity
Safizadeh, F., Mandic, M., Hoffmeister, M., & Brenner, H. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54753 · Cited by 36
Obesity as an Avoidable Cause of Cancer (Attributable Risks)
Renehan, A. G., & Soerjomataram, I. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_13 · Cited by 37
Self-citationChung, H. S., Lee, J. S., Song, E., Kim, J. A., Roh, E., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1262 · Cited by 33
“Insulin resistance-related cancers have been suggested to be directly and indirectly affected by sex hormones (26).”
BackgroundPark, K. E., Kim, E. S., Chin, H.-M., Yoon, D., & Jun, K. (2022) · Oncology Reports · doi:10.3892/or.2022.8377 · Cited by 33
“One‐third of women with a normal BMI have symptoms characteristic of metabolic obesity, while 30% of obese individuals can be classified as metabolically healthy (6,7).”
BackgroundTaube, M., Peltonen, M., Sjöholm, K., Anveden, Å., Andersson‐Assarsson, J. C., Jacobson, P., Svensson, P., Bergö, M. O., & Carlsson, L. M. S. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.3240 · Cited by 34
Dagpo, T., Nolan, C. J., & Delghingaro‐Augusto, V. (2020) · Cells · doi:10.3390/cells9071596 · Cited by 35
Visceral fat measured by computed tomography and the risk of breast cancer
Kim, M. S., Choi, Y., & Lee, Y. H. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.09.16 · Cited by 31
“Obesity has been indicated as a risk factor for breast cancer in post-menopausal women (12-14).”
BackgroundEnvironmental Risk Factors for Gallbladder Cancer: Field-Wide Systematic Review and Meta-Analysis
Piovani, D., Nikolopoulos, G. K., Aghemo, A., Lleò, A., Alqahtani, S. A., Hassan, C., Repici, A., & Bonovas, S. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.07.046 · Cited by 37
Epigenetic Influences in the Obesity/Colorectal Cancer Axis: A Novel Theragnostic Avenue
Ayers, D., Boughanem, H., & Macías‐González, M. (2019) · Journal of Oncology · doi:10.1155/2019/7406078 · Cited by 30
“The ectopic local adiposity corresponds to inflammation and was mainly associated with colon and pancreatic cancer, breast tumorigenesis, and hepatocellular carcinoma [10, 11].”
BackgroundJensen, B. W., Bjerregaard, L. G., Ängquist, L. H., Gögenür, I., Renehan, A. G., Osler, M., Sørensen, T. I. A., & Baker, J. L. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0109-y · Cited by 33
“Overweight is thought to increase colon cancer risk by causing elevated levels of insulin-like growth factor-1, altered levels of adiponectin and leptin, and a chronic exposure to low-grade inflammation both in the local microenvironment and overall systemic inflammation [22].”
Self-citationHofmann, J. N., Mailankody, S., Korde, N., Wang, Y., Tageja, N., Costello, R., Zingone, A., Hultcrantz, M. L., Pollak, M., Purdue, M. P., et al. (2017) · Obesity · doi:10.1002/oby.21894 · Cited by 32
“2) Immunoglobulin type IgG 56 (67) 71 (68) 15 (60) IgA 15 (18) 21 (20) 7 (28) IgM 8 (10) 1 (1) 0 (0) Biclonal 4 (5) 2 (2) 0 (0) Light chain 1 (1) 9 (9) 3 (12) Mean M-spike concentration, g/L (SD) 0.”
The Obesity Paradox and Mortality After Colorectal Cancer: A Causal Conundrum
Renehan, A. G., & Sperrin, M. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0868 · Cited by 32
Self-citationPerego, S., Sansoni, V., Ziemann, E., & Lombardi, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042005 · Cited by 30
“The mechanisms underlying the association between adiposity and neoplastic transformation are the same as for sedentary behavior, namely metabolic dysfunction, increased levels of sex hormones, LGI, and inflammatory mediators (cytokines and adiposity-related adipokines) [14,15].”
BackgroundSanchez‐Pino, M. D., Gilmore, L. A., Ochoa, A. C., & Brown, J. C. (2021) · Obesity · doi:10.1002/oby.23108 · Cited by 32
“Additionally, impaired fat tissue promotes polarization shifts of myeloid cells and systemic and local chronic low- grade inflammation (2).”
BackgroundArgano, C., Natoli, G., Mularo, S., Nobili, A., Monaco, M. L., Mannucci, P. M., Perticone, F., Pietrangelo, A., & Corrao, S. (2022) · Healthcare · doi:10.3390/healthcare10010086 · Cited by 33
“In this sense, hyperglycemia induces a proliferative, anti-apoptotic, and metastatic effect [34], and hyperinsulinemia and obesity promote tumorigenesis [35,36].”
BackgroundDonin, N. M., Pantuck, A. J., Klöpfer, P., Bevan, P., Fall, B., SAID, J. W., Belldegrun, A. S., & Chamie, K. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0226 · Cited by 30
“Various other putative biochemical pathways linking obesity to cancer progression are the subjects of active research (26).”
BackgroundFerroptosis, Metabolic Rewiring, and Endometrial Cancer
Žalytė, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010075 · Cited by 32
Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
Kelkar, S., Oyekunle, T. O., Eisenberg, A., Howard, L. E., Aronson, W. J., Kane, C. J., Amling, C. L., Cooperberg, M. R., Klaassen, Z. W. A., Terris, M. K., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab023 · Cited by 29
“8) 1404 (38) 633 (41) 1189 (38) Other 38 (4.”
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women
Romanos-Nanclares, A., Tabung, F. K., Sinnott, J. A., Trabert, B. L., Vivo, I. D., Playdon, M. C., & Eliassen, A. H. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac229 · Cited by 28
Campbell, K. L., Landells, C. E., Fan, J., & Brenner, D. R. (2017) · Obesity · doi:10.1002/oby.22010 · Cited by 29
“LEP is an interesting candidate in the context of carcinogenesis because of the mitogenic, antiapoptotic, and proinflammatory properties (27) and the opposite properties for adiponectin (28).”
BackgroundFatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Mentoor, I., Engelbrecht, A., & Nell, T. A. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.11.009 · Cited by 29
Nattenmüller, J., Rom, J., Buckner, T., Arvin, J., Bau, B., Sohn, C., Kauczor, H., & Schott, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24667 · Cited by 27
“Recently, it has been shown that beyond BMI local fat deposits, especially visceral abdominal fat tissue (VAT), are associated with an increased risk of colon carcinoma [10, 27].”
BackgroundAssociation Between Western and Mediterranean Dietary Patterns and Mammographic Density
Castelló, A., Ascunce, N., Salas‐Trejo, D., Vidal, C., Sánchez‐Contador, C., Santamariña, C., Pedraz‐Pingarrón, C., Moreno, M. P., Pérez‐Gómez, B., Lope, V., et al. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001589 · Cited by 31
“1 887 (25) 223 (25) 200 (23) 277 (31) 187 (21)”
InfluentialEnhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation
Scully, T., Scott, C. D., Firth, S. M., Sedger, L. M., Pintar, J. E., Twigg, S. M., & Baxter, R. C. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0384 · Cited by 29
Kawachi, A., Shimazu, T., Budhathoki, S., Sawada, N., Yamaji, T., Iwasaki, M., Inoue, M., & Tsugane, S. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000449 · Cited by 27
the Australian Ovarian Cancer Study Group, Minlikeeva, A. N., Cannioto, R. A., Jensen, A., Kjær, S. K., Jordan, S. J., Diergaarde, B. B., Szender, J. B., Odunsi, K. O., Almohanna, H., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01157-3 · Cited by 29
Prognostic Factors in Advanced Ovarian Cancer - A Clinical Trial
Dinca, A. L., Bîrlă, R., Dincă, V. G., Marica, C. D., Panaitescu, E., & Constantinoiu, S. M. (2020) · Chirurgia · doi:10.21614/chirurgia.115.1.50 · Cited by 27
“(27) Obese women with ovarian cancer receive less aggressive treatment to avoid adverse reactions.”
BackgroundResultFritz, J., Jochems, S. H. J., Bjørge, T., Wood, A., Häggström, C., Ulmer, H., Nagel, G., Zitt, E., Engeland, A., Harlid, S., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02526-1 · Cited by 27
Body composition and risk of gastric cancer: A population‐based prospective cohort study
Liu, A.-R., He, Q., Wu, W., Du, J., Kuo, Z., Xia, B., Tang, Y., Yun, P., Cheung, E. C., Tang, Y.-Z., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3808 · Cited by 26
Modulation of T Cell Activation in Obesity
Morin, S. O., Poggi, M., Alessi, M., Landrier, J., & Nunès, J. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6746 · Cited by 26
“Additionally, obesity is associated with an increased risk of cancers derived from different tissues (76).”
Diets link metabolic syndrome and colorectal cancer development
Saetang, J., & Sangkhathat, S. (2017) · Oncology Reports · doi:10.3892/or.2017.5385 · Cited by 28
Liao, L. M., Hofmann, J. N., Cho, E., Pollak, M., Chow, W., & Purdue, M. P. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0901-3 · Cited by 26
“Obesity is an established risk factor for RCC, but the specific biological mechanisms through which obesity acts to increase the risk of this malignancy are unclear [2].”
Rosendahl, A. H., Bergqvist, M., Lettiero, B., Kimbung, S., & Borgquist, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00689 · Cited by 28
Adiposity and cancer: systematic review and meta-analysis
Watts, E. L., Gonzalez‐Feliciano, A. G., Gunter, M. J., Chatterjee, N., & Moore, S. C. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01542-8 · Cited by 27
Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status
Hanyuda, A., Cao, Y., Hamada, T., Nowak, J. A., Qian, Z. R., Masugi, Y., da Silva, A., Liu, L., Kosumi, K., Soong, T. R., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0254-y · Cited by 28
Childhood Overweight, Tallness, and Growth Increase Risks of Ovarian Cancer
Aarestrup, J., Trabert, B. L., Ulrich, L. G., Wentzensen, N., Sørensen, T. I. A., & Baker, J. L. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0024 · Cited by 27
“Adult adiposity may be linked to ovarian carcinogenesis through influences on the bioavailability or synthesis of endogenous sex hormones (24, 25).”
BackgroundOral hygiene might prevent cancer
Cordero, O. J., & Varela‐Calviño, R. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00879 · Cited by 28
“There are still many challenges exploring the association of cancer with overweight and obesity, but consensus exists about that long-term efforts in prevention should remain focused not only on further reduction of smoking but also engaging in healthy lifestyles, balanced diets and regular physical exercise [58, 61,…”
BackgroundWang, Y., Hung, A. C., Wu, Y., Lo, S. J., Chen, H., Chen, Y.-K., Hsieh, Y.-C., Hu, S. C., Hou, M., & Yuan, S. F. (2022) · Scientific Reports · doi:10.1038/s41598-022-19290-6 · Cited by 26
Adipokines as Regulators of Autophagy in Obesity-Linked Cancer
García-Miranda, A., García-Hernández, A. P., Castañeda-Saucedo, E., Navarro‐Tito, N., & Maycotte, P. (2022) · Cells · doi:10.3390/cells11203230 · Cited by 24
“For different cancer sites, studies have described similar risk estimates in pancreatic, endometrium and ovarian cancers for BMI and WC [3,12].”
BackgroundCoronary Revascularization in Patients With Cancer
Pushparaji, B., Donisan, T., Balanescu, D. V., Park, J. K., Monlezun, D. J., Ali, A., İnanç, İ. H., Caballero, J. A., Çilingiroğlu, M., Marmagkiolis, K., et al. (2023) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-023-00982-9 · Cited by 24
Yao, P., Iona, A., Kartsonaki, C., Said, S., Wright, N., Lin, K., Pozarickij, A., Millwood, I. Y., Fry, H., Mazidi, M., et al. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-01038-9 · Cited by 26
“There were 786 overlapping proteins between men and women and with exception of nine proteins, all the associations were directionally consistent (eFigure 6).”
Castro‐Espín, C., Agudo, A., Bonet, C., Katzke, V., Fortner, R. T., Aleksandrova, K., Schulze, M. B., Tjønneland, A. M., Dahm, C. C., Quirós, J. R., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00772-2 · Cited by 24
Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial
Yeh, H., Maruthur, N. M., Wang, N., Jerome, G. J., Dalcin, A., Tseng, E., White, K. N., Miller, E. R., Juraschek, S. P., Mueller, N. T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab266 · Cited by 24
“Titration of metformin in an open-label fashion occurred as follows, largely based on tolerance at each dose level: (1) start with 500 mg by mouth once daily with breakfast for 7 days or longer if needed; (2) increase metformin to 500 mg by mouth twice daily with breakfast and dinner for 7 days or longer if needed; (3…”
BackgroundMethodInfluentialSystemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential
Holly, J. M. P., Biernacka, K. M., & Perks, C. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00065 · Cited by 26
Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal
Miguel, L. S., Soares, M., Olivieri, A., Sampaio, F., Lamotte, M., Shukla, S., Conde, V., Freitas, P., Costa, J. N., & Borges, M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01338-4 · Cited by 24
“…and post-menopausal endometrial cancers were sourced from the International Agency for Research on Cancer [30], and hazards ratios by BMI for colon cancer from Schlesinger et al. [31] and for post-menopausal breast and endometrial cancers from two systematic reviews and meta-analyses [32, 33].”
MethodBonet, C., Crous‐Bou, M., Tsilidis, K. K., Gunter, M. J., Kaaks, R., Schulze, M. B., Fortner, R. T., Antoniussen, C. S., Dahm, C. C., Mellemkjær, L., et al. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00979-5 · Cited by 26
“Several biological mechanisms could explain the effects of excess body fatness on BC mortality and progression [25].”
BackgroundOn the Role of Glycolysis in Early Tumorigenesis—Permissive and Executioner Effects
Marcucci, F., & Rumio, C. (2023) · Cells · doi:10.3390/cells12081124 · Cited by 26
“First of all, clinical conditions characterized by hyperglycemia such as type II diabetes and obesity are associated with an increased incidence of several cancer types such as CRC, hepatocellular carcinoma, breast, renal, bladder, and pancreatic cancer [33,34].”
BackgroundAnari, M., & Montgomery, M. K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115621 · Cited by 24
Sato, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01474-4 · Cited by 24
“Many of these secretory factors exert clinical effects on cancer progression according to previous studies [15–18].”
BackgroundSon, M., Moon, S. Y., Koh, M., Kang, Y. W., & Lee, J. Y. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061628 · Cited by 23
“CRC in this cytokines and adipokines from adipose tissue [13,34,35].”
BackgroundBeneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer
Anastasiou, I. A., Kounatidis, D. C., Vallianou, N. G., Skourtis, A., Dimitriou, K., Tzivaki, I., Tsioulos, G., Rigatou, A., Karampela, Ι., & Dalamaga, Μ. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01654-6 · Cited by 29
“This condition not only precedes T2DM but is also a known risk factor for cancers, such as those of the prostate, colon, kidneys, and endometrium, driven by increased IGF-1 and insulin [61].”
Marinozzi, M. R., Pandolfi, L., Malatesta, M., Colombo, M., Collico, V., Lievens, P., Tambalo, S., Lasconi, C., Vurro, F., Boschi, F., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.013 · Cited by 26
van Weelden, W. J., Fasmer, K. E., Tangen, I. L., IntHout, J., Abbink, K., van Herwaarden, A. E., Krakstad, C., Massuger, L. F. A. G., Haldorsen, I. S., & Pijnenborg, J. M. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5770-6 · Cited by 23
Safizadeh, F., Mandic, M., Schöttker, B., Hoffmeister, M., & Brenner, H. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01680-7 · Cited by 26
“…measures such as WHR alongside BMI into routine clinical practice for more effective prevention and management of obesity, whose prevalence is steadily increasing in many countries worldwide, in order to limit the global burden of CRC and many other obesity-related adverse health outcomes.”
Lynch, B. M., Milne, R. L., English, D. R., Brown, K. A., Drummond, A. E., Swain, C. T. V., van Roekel, E. H., Moore, M. M., Gaunt, T. R., Martin, R. M., et al. (2022) · PubMed Central · doi:10.1158/1055-9965.epi-21-0435 · Cited by 10
Insulin-like growth factor binding protein-3 links obesity and breast cancer progression
Scully, T., Firth, S. M., Scott, C. D., de Silva, H. C., Pintar, J. E., Chan‐Ling, T., Twigg, S. M., & Baxter, R. C. (2016) · Oncotarget · doi:10.18632/oncotarget.10675 · Cited by 25
“These include increased levels of circulating insulin/IGFs, sex hormones and cytokines released from adipose tissue [15] and the development of a tumor-supportive microenvironment [16, 17].”
BackgroundWaist Circumference Might Be a Predictor of Primary Liver Cancer: A Population-Based Cohort Study
Wei, L., Li, N., Wang, G., Feng, X., Lyu, Z., Li, X., Wen, Y., Chen, Y., Chen, H., Chen, S., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00607 · Cited by 22
The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan
Okura, Y., Ozaki, K., Tanaka, H., Takenouchi, T., Sato, N., & Minamino, T. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0426 · Cited by 23
Arthur, R., Xue, X., Kamensky, V., Chlebowski, R. T., Simon, M. S., Luo, J., Shadyab, A. H., Neuhouser, M. L., Banack, H. R., Ho, G. Y. F., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2690 · Cited by 21
Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits
Giovannantonio, M. D., Harris, B. H. L., Zhang, P., Kitchen-Smith, I., Xiong, L., Sahgal, N., Stracquadanio, G., Wallace, M. D., Blagden, S. P., Lord, S., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106799 · Cited by 22
Cancer du sein, obésité et tissu adipeux: Un trio à haut risque
Fallone, F., Deudon, R., Muller, C., & Vaysse, C. (2018) · médecine/sciences · doi:10.1051/medsci/2018298 · Cited by 29
Lone, I. M., Midlej, K., Nun, N. B., & Iraqi, F. A. (2023) · Mammalian Genome · doi:10.1007/s00335-023-09979-y · Cited by 22
“Insulin is also an important growth factor of colonic epithelial cells and is a mitogen of tumor cell growth in vitro (Gallagher and LeRoith 2010; Renehan et al. 2015).”
BackgroundOgony, J. W., Radisky, D. C., Ruddy, K. J., Goodison, S., Wickland, D. P., Egan, K. M., Knutson, K. L., Asmann, Y. W., & Sherman, M. E. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0562 · Cited by 22
Choi, Y., Ahn, K. J., Park, S.-K., Cho, H., & Lee, J. Y. (2016) · Radiation Oncology Journal · doi:10.3857/roj.2016.01977 · Cited by 21
“Several clinical studies [5,6,8] have explained the association between obesity and incidence of cancers such as colon cancer, breast cancer, endometrial cancer, cervical cancer, and ovarian cancer.”
BackgroundPathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia
Grega, T., Vojtěchová, G., Gregová, M., Zavoral, M., & Suchánek, Š. (2021) · Physiological Research · doi:10.33549/physiolres.934631 · Cited by 21
“Activation of these receptors suppresses inflammation, increases cell sensitivity to insulin, induces apoptosis, and inhibits cell proliferation (Renehan et al. 2015).”
BackgroundCausal roles of circulating adiponectin in osteoporosis and cancers
He, B., Zhao, J., Zhang, M., Yin, L., Quan, Z., Ou, Y., & Huang, W. (2021) · Bone · doi:10.1016/j.bone.2021.116266 · Cited by 21
Sedlmeier, A. M., Viallon, V., Ferrari, P., Peruchet‐Noray, L., Fontvieille, E., Amadou, A., Khoei, N. S., Weber, A., Baurecht, H., Heath, A. K., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02071-3 · Cited by 22
“One of these two single-nucleotide polymorphisms has previously been associated with increased levels of circulating adiponectin [16], which has been implicated in cancer development [37].”
BackgroundLipids and adipocytes involvement in tumor progression with a focus on obesity and diet
Calabrese, C., Miserocchi, G., Vita, A. D., Spadazzi, C., Cocchi, C., Vanni, S., Gabellone, S., Martinelli, G., Ranallo, N., Bongiovanni, A., et al. (2024) · Obesity Reviews · doi:10.1111/obr.13833 · Cited by 23
“4 – 6 A high BMI is also linked to a more aggressive disease and adverse outcomes in prostate cancer.”
Development of MR quantified pancreatic fat deposition as a cancer risk biomarker
Coe, P. O., Williams, S. R., Morris, D. M., Parkin, E., Harvie, M., Renehan, A. G., & O'Reilly, D. A. (2018) · Pancreatology · doi:10.1016/j.pan.2018.04.001 · Cited by 21
Self-citationWang, K., Chen, X., Gerke, T. A., Bird, V. Y., Ghayee, H. K., & Prosperi, M. (2018) · Cancer Medicine · doi:10.1002/cam4.1747 · Cited by 20
Reproductive factors, obesity and risk of colorectal cancer in a cohort of Asian women
Wong, T. S.-H., Chay, W. Y., Tan, M., Chow, K. Y., & Lim, W. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.10.016 · Cited by 20
Szyszka, M., Paschke, L., Tyczewska, M., Jopek, K., Celichowski, P., Milecka, P., Sultanova, G., Stelcer, E., Malińska, A., Malendowicz, L. K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215412 · Cited by 20
Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations
Osataphan, S. A., Mahankasuwan, T., & Saengboonmee, C. (2021) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.1001 · Cited by 21
Drummond, A. E., Swain, C. T. V., Milne, R. L., English, D. R., Brown, K. A., Skinner, T. L., Lay, J., van Roekel, E. H., Moore, M. M., Gaunt, T. R., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0505 · Cited by 22
Obesity and p16 INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity
Al‐Khalaf, H. H., Amir, M., Almohanna, F., Tulbah, A. M., Alsayed, A., & Aboussekhra, A. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00101-17 · Cited by 19
“This implies that p16 represses the proliferative/migratory abilities of adipocytes through targeting leptin and the inhibition of the AKT and ERK1/2 pathways.”
BackgroundInfluentialChen, Z., Ding, C., Chen, K., Gu, Y., Qiu, X., & Li, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-66414-1 · Cited by 20
Obesity and Cancer: Concepts and Challenges
Argolo, D. F. S. D. T. E., Iyengar, N. M., & Hudis, C. A. (2015) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-015-0483-z · Cited by 19
“Adiponectin, which is secreted only by mature adipocytes, is the most abundant adipokine and has anti-inflammatory activity [63].”
Body Mass Index and Cancer Mortality Among Korean Older Middle-Aged Men: A Prospective Cohort Study
Hong, J., Yi, S., Yi, J., Hong, S., & Ohrr, H. (2016) · Medicine · doi:10.1097/md.0000000000003684 · Cited by 20
Metadata
- Authors
- Renehan, A. G., Zwahlen, M., & Egger, M.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Bern (CH)
- Corresponding author
- Renehan, Andrew G.
- Venue
- Nature Reviews Cancer
- Published
- 2015-07-24
- Volume
- 15
- Issue
- 8
- Pages
- 484-498
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1685808974
- Cited by
- 654
- References
- 173
- Citations by year
- 2026: 40 · 2025: 57 · 2024: 71 · 2023: 64 · 2022: 55 · 2021: 69 · 2020: 54 · 2019: 58 · 2018: 54 · 2017: 68 · 2016: 56 · 2015: 7
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
- boris.unibe.ch
- Licence
- cc-by-nc
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Institute for Cancer Research
- Cancer Research UK
- Medical Research Council (MR/K006665/1, MC_PC_13042)
- Economic and Social Research Council (ES/F029721/1, ES/J010014/1)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- obesity, adiposity, cancer risk, body mass index, sex differences, tumor location, histological subtypes, molecular phenotypes, biological mechanisms, cancer prevention
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Obesity, Risk Factors, Body Mass Index, Incidence, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.